VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1410075
Sex: M
Age: 59
State:

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: right arm sore with difficulty lifting the arm without pain, stomach spasms, throat feels like closing off, coughing Narrative: Patient received vaccine on 01/26/2021. Was assessed per the protocol and showed no signs of being unwell and was healthy looking. Vaccine was administered IM to RT arm. Patient then was monitored for 15 mins by staff over seeing monitor in clinic that day. After 15 mins time, patient was released. Pt call the call center the next day 01/27/2021 with a complaint of stomach spasms, sore arm that is difficult to lift with out pain being present, feeling like his throat is going to close off and starts to cough.

Other Meds:

Current Illness:

ID: 1410076
Sex: M
Age: 70
State:

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 02/09/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Narrative:

Other Meds:

Current Illness:

ID: 1018315
Sex: M
Age:
State: PR

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Thirst; dehydration; This is a spontaneous report from a non-contactable consumer. This report was received via a sales representative. An adult male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration on an unspecified date in Jan2021 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previous received the first dose of bnt162b2 in Dec2020 for covid-19 immunization. The patient experienced thirst and dehydration on Jan2021. The outcome of the events was recovered in Jan2021 at the time of last observation. No treatment received for the events. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1018316
Sex: M
Age:
State: PR

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lymphadenitis; This is a spontaneous report from a non-contactable consumer. An adult male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown), via an unspecified route of administration on Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on Dec2020 for COVID-19 immunization. The patient experienced lymphadenitis on Jan2021. It was unknown if the patient received treatment for this. Outcome of the event was recovered on Jan2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1018318
Sex: U
Age:
State: IL

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: improperly stored vaccine was administered; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 25-JAN-2021, the patient was vaccinated with an improperly stored dose of hepatitis b vaccine (recombinant) (thimerosal free) (RECOMBIVAX HB) 1 injection, (lot # T004378, expiration date reported as 31-OCT-2022, but upon internal validation stablished as 01-NOV-2022 (dose, route of administration and anatomical location were not reported) for prophylaxis. The administered dose of vaccine was stored in the temperature of above 9 degrees Celsius (13.4 degrees Celsius) for 2 hours and 9 minutes. There were no previous temperature excursions reported. The improper storage was recorded by digital data logger. This is one of multiple reports from the same reporter.; Sender's Comments: US-009507513-2101USA013389: US-009507513-2101USA013543: US-009507513-2101USA013730: US-009507513-2102USA000172: US-009507513-2102USA000195: US-009507513-2102USA000219:

Other Meds:

Current Illness:

ID: 1018319
Sex: U
Age:
State: MN

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No additional AEs no PQCs; Temperature: -13.7C; This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 01-FEB-2021, the patient was vaccinated with dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (rHA) lot # T025222, expiration date: 19-JAN-2022 (formulation, strength, dose, frequency and route of administration were not reported) for prophylaxis. On an unknown date, the dose of the vaccine was exposed to temperature excursion at - 13.7 Celsius degrees (C) for 42 minutes. There was no previous temperature excursion reported. The call was not due to digital data logger. No additional adverse event was reported.

Other Meds:

Current Illness:

ID: 1018320
Sex: M
Age: 0
State: NY

Vax Date: 12/13/2019
Onset Date: 12/13/2019
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: product storage error; This spontaneous report was received from a licensed practical nurse regarding a 1 year old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 13-DEC-2019, the patient received improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # S037501, expiration date of 12-NOV-2021, subcutaneous in the right thigh , varicella virus vaccine live (oka/merck)(VARIVAX) lot # T017686 with expiration date of 21-MAY-2022, subcutaneous in the left thigh, hepatitis a virus vaccine inactivated(HAVRIX) lot # N592C with expiration date of 12-JUN-2022, intramuscular in the right vastus lateralis and pneumococcal 13v conj vaccine (crm197)(PREVNAR 13) lot # D57723 with expiration date of 30-SEP-2022 intramuscular in the left vastus lateralis, all for prophylaxis The vaccines experienced temperature excursions with a total of 29.5h. This is one of several reports from the same reporter(US-009507513-2101USA011364).; Sender's Comments: US-009507513-2101USA011364:

Other Meds:

Current Illness: Prophylaxis

ID: 1018321
Sex: M
Age: 4
State: NY

Vax Date: 12/14/2020
Onset Date: 12/14/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: PRODUCT STORAGE ERROR; This spontaneous report was received from a licensed practical nurse regarding a 4 year old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 14-DEC-2020, the patient received improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # S037501, expiration date of 20-NOV-2021, subcutaneous in left arm and varicella virus vaccine live (oka/merck)(VARIVAX) lot # T017686 with expiration date of 21-MAY-2022, subcutaneous in the left arm for prophylaxis. The vaccines experienced temperature excursions with a total of 29.5h. This is one of several reports from the same reporter(US-009507513-2101USA011364).; Sender's Comments: US-009507513-2101USA011364:

Other Meds:

Current Illness:

ID: 1018322
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash on his head; This spontaneous report was received from an unspecified reporter and refers to a 4 month old male patient. . No information was provided regarding medical history, concurrent conditions, or concomitant medications. On an unknown date, the patient was vaccinated with the second dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (strength, dose, frequency, lot # and expiration date were not reported) for prophylaxis. On an unknown date the patient experienced presented with a rash on his head but it did go away. Causality was not provided.

Other Meds:

Current Illness:

ID: 1018323
Sex: U
Age: 0
State: NV

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No additional AE details are available; AE for ROTATEQ which was administered after improper storage; This spontaneous report was received from a medical assistant and refers to a 6-month-old patient. The patient's medical history, historical drugs, previous drug reactions, allergies, concurrent conditions, and concomitant therapies were not reported. On 01-FEB-2021, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 0.5 milliliters, orally, lot number 1742461, and expiration date on 17-NOV-2021 (formulation, strength, frequency, and anatomical location were not reported) for prophylaxis. No additional adverse event details were available. The administered dose of vaccine experienced the temperature excursion of 9.9 degrees Celsius for 35 minutes. The previous temperature excursion was not reported. Data logger was involved.

Other Meds:

Current Illness:

ID: 1018324
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: varicella rash; This spontaneous report was received from a physician and refers to a patient of unknown age and gender with heart disease congenital. Te patient's medical history and concomitant medications was not provided. On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX)(strength, dose, frequency, lot # and expiration date were not provided) for prophylaxis. On an unknown date, the patient experienced a new varicela rash(rash vesicular). The outcome of rash vesicular was unknown. The reporter considered rash vesicular to be related to varicella virus vaccine live (Oka/Merck)(VARIVAX).

Other Meds:

Current Illness: Heart disease congenital

ID: 1018325
Sex: U
Age: 82
State: TX

Vax Date: 10/21/2013
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: other zoster related injuries; shingles; Information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown gender who at the time of vaccination with zoster vaccine live (ZOSTAVAX) was 82 years old. No information about the pt's medical history, concurrent conditions or concomitant medications was provided. On or about 21-OCT-2013, the pt was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) by a pharmacist at a pharmacy for the long-term prevention of shingles and zoster-related conditions. Subsequently, on unknown dates, the pt was treated by a physician at a family care facility for the following injuries resulting from the pt's zoster vaccine live (ZOSTAVAX) use: shingles and other zoster related injuries. The outcome of the events was not provided. The reporter considered the events of shingles and other zoster related injuries to be related to zoster vaccine live (ZOSTAVAX).

Other Meds:

Current Illness:

ID: 1018326
Sex: U
Age:
State:

Vax Date: 12/21/2020
Onset Date: 12/01/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; Sore arm; Swollen arm; . This case was reported by a consumer and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On 21st December 2020, the patient received the 2nd dose of Shingrix. In December 2020, less than a week after receiving Shingrix, the patient experienced fever, pain in arm and swelling arm. On an unknown date, the outcome of the fever, pain in arm and swelling arm were not recovered/not resolved. It was unknown if the reporter considered the fever, pain in arm and swelling arm to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. It was reported that patient received the 2nd dose of Shingrix and experinced fever, sore arm and arm swelling. Patient asked regarding how long the side effects such as fever generally last.

Other Meds:

Current Illness:

ID: 1018327
Sex: F
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe shivering, was so bad that she could not dial a phone; severe headache; nausea; dizziness; had her first dose in April or May of 2019.; This case was reported by a consumer and described the occurrence of shivering in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (intramuscular) and the 2nd dose of Shingrix. On an unknown date, 30 min after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shivering, headache, nausea, dizziness and incomplete course of vaccination. On an unknown date, the outcome of the shivering, headache, nausea and dizziness were recovered/resolved and the outcome of the incomplete course of vaccination was unknown. It was unknown if the reporter considered the shivering, headache, nausea and dizziness to be related to Shingrix. Additional information was provided as follows: The age at vaccination was not applicable for the 2nd dose. The patient did not receive the 2nd dose of Shingrix as per the vaccination schedule, which led to incomplete course of vaccination. In April or May 2019, the patient received 1st dose of Shingrix and experinced severe shivering so bad that she could not dial a phone, severe headache, nausea and dizziness. The symptoms lasted approximately an hour before reducing in severity but had not resolved until 6 to 8 hours later. The reporter consented to follow up.

Other Meds:

Current Illness:

ID: 1018328
Sex: F
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Collapsed on the floor; Left arm injection site red; Rash; A spontaneous report was received from a consumer, who was also a 80-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced syncope, injection site redness, rash, and headache. The patient's medical history, as provided by the reporter, included high blood pressure. Concomitant product use reported included atenolol and atorvastatin. On 11 Jan 2021, one day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: 039K20A) intramuscularly in the left arm for the prophylaxis of COVID-19 infection. On 12 Jan 2021, the patient noticed her left arm was getting redder and redder at the injection site. When she turned to look at the clock, the patient collapsed on the floor. She went to the medical center and was prescribed prednisone and diphenhydramine. On 21 Jan 2021, the patient reported she now had a headache that began on an unspecified date, and that her injection site redness and rash were still present, but getting better. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event, syncope, was unknown. The events, injection site redness and rash, were considered resolving. The event, headache, was considered not resolved.; Reporter's Comments: This spontaneous report concerns an 80-year-old, female patient with medical history of high blood pressure who experienced serious event of syncope and non-serious events of injection site redness, rash and headache. The events of syncope rash and injection site redness occurred 1 day after administration of mRNA-1273 (Batch number: 039K20A, expiration date-unknown). On an unspecified date on the event of headache began. Treatment provided for the events included prednisone and diphenhydramine and the outcome is not resolved. injection site redness, rash and headache are consistent with the known safety profile of the mRNA-1273 Vaccine and hence, based on the temporal association between the events and the vaccine administration, a causal association cannot be excluded

Other Meds: ATENOLOL; ATORVASTATIN

Current Illness: Blood pressure high

ID: 1018329
Sex: F
Age:
State: NY

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: she got the first dose of the covid vaccine on 04Jan, scheduled to get the second dose of the covid vaccine on 24Jan; experiencing runny nose; colds; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age was scheduled to get the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 25Jan2021 11:28 at single dose for covid-19 immunization. Medical history included chronic obstructive pulmonary disease, ongoing torn rotator cuffs. The patient also believed she was immunocompromised. The patient confirmed that the shoulder pain that she was getting the Cortisone shot for was prior to the COVID shot and she had been getting them for some time. The patient previously took prednisone regularly and took BNT162b2 (Batch/lot number: EL0142, Expiry Date: 20Mar2021) via an unspecified route of administration on 04Jan2021 at single dose for covid-19 immunization and had swelling and pain on the arm that was injected on an unspecified date in Jan2021. Also, she had a fever and felt lethargic that night but the next day she felt fine. The caller clarified that the next day she actually could hardly get out of bed and felt fatigued and tired. Her temperature reached 100.7. This happened on 05Jan2021. The patient's concomitant medication was not reported. Caller asking if she can have the second dose of the covid vaccine if she was scheduled for a cortisone injection to both of her shoulders. Caller reported that she got the first dose of the covid vaccine on 04Jan, she was now scheduled to have cortisone injections to both of her shoulders for torn rotator cuffs on 13Jan and then scheduled to get the second dose of the covid vaccine on 24Jan. The patient got the second dose of the vaccine on 25Jan2021 11:28 and is experiencing runny nose and colds. The outcome of the events was unknown. Follow-up (25Jan2021): New information received from a contactable consumer includes: additional events (runny nose, and colds). Information on the batch/lot number has been requested.

Other Meds:

Current Illness: Immunocompromised; Rotator cuff tear (scheduled to have cortisone injections); Shoulder pain (getting the Cortisone shot)

ID: 1018330
Sex: F
Age:
State: MI

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: post injection experienced tingling, burning pain over left clavicle and into L neck; post injection experienced tingling, burning pain over left clavicle and into L neck; post injection experienced tingling, burning pain over left clavicle and into L neck; nerve pain (hyperaesthesia, tingling, zinging); nerve pain (hyperaesthesia, tingling, zinging); nerve pain (hyperaesthesia, tingling, zinging); This is a spontaneous report from a contactable physician. An adult non-pregnant female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection) intramuscularly on 22Dec2020 at 19:45 as a single dose in the left arm for COVID-19 immunization. Medical history included seasonal allergies and known allergies: sensitivity to toluene and strong fragrances, from unspecified dates and unspecified if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications (reported as other medications in two weeks) included clarithromycin (CLARITIN) taken for an unspecified indication from an unspecified date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Dec2020 at 19:45 the patient experienced "post injection experienced tingling, burning pain over left clavicle and into L neck" and "nerve pain (hyperaesthesia, tingling, zinging)". The clinical course was reported as follows: "Injection was painless, starting 5-10 minutes post injection the patient experienced tingling, burning pain over left clavicle and into L (left) neck. No associated rash, redness, color or temperature change. No swallowing or breathing difficulty. Nerve pain (hyperaesthesia, tingling, zinging) persisted 3 weeks later at lower intensity over medial clavicle and supraclavicular fossa aggravated by clothing, Valsalva, certain L arm movements." The adverse events resulted in a doctor or healthcare professional office/clinic visit. Treatment was given in response to the events and included gabapentin. The clinical outcomes of the events "post injection experienced tingling, burning pain over left clavicle and into L neck" and "nerve pain (hyperaesthesia, tingling, zinging)" were recovered/resolved with sequel (with lasting effects). It was also reported that the patient was tested for COVID-19 post vaccination on 04Jan2021, with a nasal swab, which was negative. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: CLARITIN [CLARITHROMYCIN]

Current Illness:

ID: 1018331
Sex: F
Age:
State: AZ

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Name: heart rate; Result Unstructured Data: Test Result: fast.

Allergies:

Symptoms: my feet feel so cold like ice; tingling to my hands and feet/Hand & feet tingling; leg weakness; felt like my heart pounding and racing/ fast heart rate; feeling too sick; started to feel flu like; muscle pain; fatigue; The initial report was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 24Jan2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable nurse (patient herself). A 40-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142), via intramuscular route of administration in the left arm on 15Jan2021 09:15 AM at a single dose to prevent COVID-19. Medical history included known allergies: latex. Concomitant medications in two weeks included ergocalciferol (VIT D) and cyanocobalamin (VIT B12). The patient did not have any other vaccine in four weeks. The patient previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via intramuscular route of administration in the left arm on 26Dec2020 10:30 AM. She also previously took NYQUIL and experienced known allergies. The patient was not pregnant and was not diagnosed with COVID prior to vaccination. The patient stated "I started to feel flu like around 7pm on January 15th. I had extreme muscle pain and fatigue. I woke up at 2am with what felt like my heart pounding and racing. The fast heart rate lasted about an hour. For the next +5 days, I had extreme fatigue, taking 3 hour naps at a time and still suffering from muscle pain. I attempted to go to work a couple of those days but went home half way through my shift because I was feeling too sick. Friday morning, 22Jan, I woke up feeling like I had leg weakness but I was still able to do activity normally. Saturday morning, 23Jan, I woke up with tingling to my hands and feet. I even had trouble typing at work. I made it through my shift this day with waves of muscle pain, fatigue and constant tingling to my hands and feet. Today Sunday, 24Jan I still have hand & feet tingling and my feet feel so cold like ice. I still feel 'off' overall. I plan do see my PCP this week to discuss these new symptoms in my hands and feet." The patient did not receive treatment for the events. She was not tested for COVID post vaccination. The outcome of 'heart pounding and racing/ fast heart rate' was recovered, and of remaining events was not recovered.

Other Meds: Vitamin D; vitamin B12

Current Illness:

ID: 1018332
Sex: F
Age:
State:

Vax Date: 12/01/2020
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hives in her upper thigh, toes, eyelid; Throat closed; This is a spontaneous report from a contactable consumer (patient). A female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number and Expiration Date unknown) via an unspecified route of administration in Dec2020 at single dose for COVID-19 immunisation. The patient's medical history included allergic to Penicillin. The concomitant medications were not reported. With the COVID-19 vaccine, patient had a reaction of hives in her upper thigh, toes, eyelid; went to sleep, when woke up it was pretty much gone with Benadryl. Patient have throat closed. For second dose, patient wanted to know if it be needed the EpiPen or tell ambulance just in case. Her second injection was on Sunday. As per the verbatim the patient had not administered the second dose yet. The outcome of hives in her upper thigh, toes, eyelid was recovering. The outcome of throat closed was unknown. Information on the batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1018333
Sex: F
Age:
State: VA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tachycardia; dizziness; flushed feeling; sweating to hands and back of neck; This is a spontaneous report from a contactable nurse reporting for herself. A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot:Ek4176), via an unspecified route of administration on the left arm on 12Jan2021 17:30 at a SINGLE DOSE for covid-19 immunisation. Medical history included hypertension, melanoma in situ, diverticulosis, allergies to sulfa, betadine and reacted to depo-medrol injection. Concomitant medication included lisinopril (LISINOPRIL), estradiol (ESTRADIOL), ibuprofen (MOTRIN) and cyanocobalamin (B12). The patient experienced tachycardia, dizziness, flushed feeling and sweating to hands and back of neck on 12Jan2021 17:30. Therapeutic measures (Benadryl 25mg) were taken as a result of the events. The outcome of the events was recovered on an unspecified date in Jan2021.

Other Meds: LISINOPRIL; ESTRADIOL; MOTRIN; B12

Current Illness:

ID: 1018334
Sex: M
Age:
State: MN

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; Chills; body aches/muscle soreness; body aches/muscle soreness; This is a spontaneous report received from non-contactable consumer (patient) via Pfizer Sales Representative. A 47-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection) via an unspecified route of administration in the left arm on 14Jan2021 15:00 at single dose for COVID-19 immunization in a hospital. Patient medical history and concomitant medications were reported as none. The patient had no other vaccines in four weeks and no other medications in two weeks. Patient previously received the first dose of BNT162B2 at the age of 47-years on 24Dec2020 at 03:00PM in the left arm, for Covid-19 immunization in a hospital. On 14Jan2021 23:00 patient experienced fever, chills, body aches/muscle soreness. No treatment was received. Patient was not tested for Covid post vaccination. Outcome of events was recovered on an unspecified date in Jan2021. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1018335
Sex: M
Age:
State: SC

Vax Date: 01/06/2021
Onset Date: 01/18/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 202007; Test Name: COVID infection; Result Unstructured Data: Test Result:infection with mild s/sx that completely resolved; Test Name: Rt-pcr; Result Unstructured Data: Test Result:Negative COVID pcr tests frequently; Test Date: 20210119; Test Name: Rt-pcr; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: Diminished capacity to draw a full breath; Mild discomfort with deep breathing; Productive cough; This is a spontaneous report from a contactable other healthcare professional, the patient. This 24-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), dose 1, single dose via intramuscular route of administration in the right arm on 06Jan2021 at 09:45 AM (at the age of 24 years-old) for COVID-19 vaccination. Relevant medical history included attention deficit disorder and allergy to non steroidal anti-inflammatory drugs . Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYNASE). The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 18Jan2021 at 06:00 AM, the patient had diminished capacity to drawa full breath that started 12 days after vaccine date and has persisted. mild discomfort with deep breathing, productive cough. Laboratory tests included negative COVID polymerase chain reaction (PCR) tests (nasal swab) on 19Jan2021 and on an unknown date. The clinical outcome of diminished capacity to draw a full breath, mild discomfort with deep breathing and productive cough was not recovered. There was no treatment received for the events. It was also reported that since the vaccination, the patient had been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: Vyvanse

Current Illness:

ID: 1018336
Sex: F
Age:
State: TX

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pulled a muscle in her back/ strained her back; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 66-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route single dose for COVID-19 immunization on Tuesday 19Jan2021, at 66-year-old. Medical history and concomitant medication were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. She stated that on 20Jan2021, Wednesday, she pulled a muscle in her back. She had strained her back and it had nothing to do with the vaccine. On Thursday, 21Jan2021, she went to the doctor and received a ketorolac tromethamine (TORADOL) injection and a triamcinolone acetonide (KENALOG) (steroid) injection to help with her back. Action taken for BNT162B2 was not applicable. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018337
Sex: F
Age:
State: VT

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210119; Test Name: PCR nasal swab; Test Result: Negative

Allergies:

Symptoms: swollen armpit lymph nodes and upper right arm; swollen armpit lymph nodes and upper right arm; arm tingling to fingers; very uncomfortable; Right armpit discomfort; This is a spontaneous report from a contactable healthcare professional (the patient). A 48-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL0140), intramuscular in the right arm on 20Jan2021 at 10:00 (at the age of 48-years-old) as a single dose for Covid-19 immunization. Medical history included central nervous system disorder (CIS) from an unknown date. The patient did not have any allergies to medications, food or other products. The patient previously received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL0140) on 30Dec2020 in the right arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Jan2021 at 18:00, the patient experienced right armpit discomfort. On 22Jan2021 the patient experienced swollen armpit lymph nodes and upper right arm leaving the right arm tingling to fingers and very uncomfortable. Therapeutic measures were not given for the events. The clinical outcome of the events axillary pain, lymphadenopathy, peripheral swelling, paresthesia and discomfort was not recovered. It was reported that since the vaccination (dose 1), the patient had been tested for COVID-19 via a PCR nasal swab on 19Jan2021 with a negative result.

Other Meds:

Current Illness:

ID: 1018338
Sex: F
Age:
State: WI

Vax Date: 01/03/2021
Onset Date: 01/04/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe body aches; headache; heavy feeling injection arm unable to lift it; cough; exhaustion; This is a spontaneous report from a contactable nurse (the patient). A 47-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL1284), via an unspecified route of administration in the left arm on 03Jan2021 13:30 (at the age of 47-years-old) as a single dose for COVID-19 immunization. Medical history included Crohn's disease and migraine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. Concomitant medications included: azathioprine sodium (IMURAN), propranolol, and sertraline hydrochloride (ZOLOFT). The patient previously took and had allergies to infliximab (REMICADE) and morphine. The patient had not received any other vaccine within 4 weeks prior to the vaccine. On 04Jan2021 07:00, the patient experienced severe body aches, headache, heavy feeling injection arm unable to lift it, cough, and exhaustion. The patient did not receive any treatment for these events. The clinical outcome severe body aches, headache, heavy feeling injection arm unable to lift it, cough, and exhaustion was recovered on an unspecified date in Jan2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: Imuran [Azathioprine Sodium]; Propranolol; Zoloft.

Current Illness:

ID: 1018339
Sex: M
Age:
State: NC

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pins and needles in the feet, toes, bottom of the feet; it's just uncomfortable and the bottom of my feet; My wife says it can be Psoriasis; This is a spontaneous report from a contactable consumer (patient). A 84-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 04Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. After vaccination, the patient park the car and all of a sudden he started to get like pins and needles they used to call in old days in his feet, in his toes. Last time he had this something like this years ago, he sat in the car too long. So, he loosen up his snickers and all and sat there, everything else was all right, a lady came over 15 minutes later and she said okay they can go. So the patient said he got some pins and needles in his feet, before he said the lady said "huh, are you having trouble breathing or anything", the patient said no he felt fine. So let they go home, and then the patient went home it's at night when he was laying down he didn't get much reaction and all. So he went up to the doctor she looked at up a few things and opened few things and the patient didn't think the doctor really had an answer for it. It was scheduled to go Monday again for the second it was still there. The patient didn't know it was probably kind of nerve reaction and all and his wife said it could be psoriasis, he never had this, it was not aggravating it's only when he walked he forgot he even had it . It's just uncomfortable and the bottom of his feet. He never had any reaction to any shot whether it was shingles or pneumonia, flu shots or whatever. The outcome of events was unknown. Information on the batch number/lot number has been requested

Other Meds:

Current Illness:

ID: 1018340
Sex: F
Age:
State: FL

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: Heart rate; Result Unstructured Data: Test Result: Increased.

Allergies:

Symptoms: Fatigue; dizziness; weakness; increased heart rate; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3302), via an unspecified route of administration on 20Jan2021 at single dose in left arm for COVID-19 immunisation. The patient was vaccinated at Nursing Home/Senior Living Facility. Patient age at vaccination was 41 Years. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history included fibromyalgia, Hashimoto's Thyroditis, allergy to Penicillin. Concomitant medications included ibuprofen (IBUPROF), loratadine (CLARITIN), sambucus nigra extract (SAMBUCOL), fluticasone propionate (FLONASE), and multivitamin. On 21Jan2021 the patient experienced fatigue, dizziness, weakness, increased heart rate, all reported as non serious. No treatment was received for the events. The events had not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19.

Other Meds: IBUPROF; CLARITIN [LORATADINE]; SAMBUCOL; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1018341
Sex: F
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; "stopped up" difficult to breathe with mask; "stopped up" difficult to breathe with mask; This is a spontaneous report from a contactable Other HCP reporting for self. A 22-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had a fever and is "stopped up" difficult to breathe with mask. Outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018342
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: shortness of breath; fatigue; back pain; This is a spontaneous report from a contactable Other Health Professional (patient). A 50-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Patient age at vaccination was 50 years old. The patient medical history and concomitant medications were not reported. Patient experienced fatigue and back pain. Patient also experienced shortness of breath and used salbutamol (ALBUTEROL). Stated she used the "machine you put the stuff in". Outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018343
Sex: F
Age:
State: NC

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: When I raised my arms up there was soreness (3-4 times in an hour or 2 hour period) where they gave the vaccine; This is a spontaneous report from a contactable Nurse (self). A 65-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22Jan2021 (at 65 years of age), as single dose for COVID-19 immunisation. Medical history was lung disease, scar tissue in lungs and Sarcoidosis. Concomitant medication was not reported. After reading the documents she realized the second dose should be scheduled 21 days after first dose. Her schedule for the second dose is 28 days after the first dose. The patient experienced "Yesterday evening (22Jan2021) when I raised my arms up there was soreness (3-4 times in an hour or 2-hour period) where they gave the vaccine." Outcome of event "When I raised my arms up there was soreness (3-4 times in an hour or 2 hour period) where they gave the vaccine" was unknown. The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1018344
Sex: M
Age:
State:

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore neck; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 22Jan2021 as a single dose for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. On 22Jan2021, an hour after receiving vaccination the patient experienced sore neck, just on the right side. The soreness was still there. The clinical outcome of the event sore neck was not recovered. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1018345
Sex: F
Age:
State: NC

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: felt a weird sensation in my throat; It felt like it was swelling and it felt different when I swallowed; felt a weird sensation in my throat; It felt like it was swelling and it felt different when I swallowed; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3249 and expiration date not provided), via an unspecified route of administration (left arm) first dose on 22Jan2021 16:30 at single dose for covid-19 immunisation. The patient's medical history included breast cancer from Jul2020 and currently cancer free. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medication included anastrozole, fluoxetine, calcium, and ergocalciferol (VIT D). On 22Jan2021, about 5 to 10 minutes after vaccination administered the patient felt a weird sensation in her throat. It felt like it was swelling, and it felt different when I swallowed. The patient could breathe fine so she waited an additional 15 minutes and it eased a bit. Since the patient had no trouble breathing she felt although her throat still felt weird. The patient went home and took Benadryl. All symptoms eased. The outcome of the events recovered.

Other Meds: ANASTROZOLE; FLUOXETINE; CALCIUM; VIT D

Current Illness:

ID: 1018346
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: caller coughing, clearing her throat; shortness of breath; feeling extremely tired; This is a spontaneous report from a contactable consumer via the Medical Information Team. A 68-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 at a single dose for COVID-19 immunization. Medical history included ongoing throat discomfort. The patient's concomitant medications were not reported. It was reported that the patient was experiencing symptoms of feeling extremely tired and shortness of breath; both on 23Jan2021. It was also reported that the patient was coughing. The outcome of the event shortness of breath was not recovered, recovering for tired while unknown for coughing. Information on the lot/batch number has been requested.

Other Meds:

Current Illness: Throat discomfort

ID: 1018347
Sex: F
Age:
State: FL

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: metallic taste in her throat; strange sensation; very rapid heart rate; This is a spontaneous report from a contactable health care professional (patient). A 45-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL9262), via an unspecified route of administration on 23Jan2021 at 08:30 on the left arm at a single dose for COVID-19 immunization. Medical history included allergy to penicillin. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included omeprazole (manufacturer unknown). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, has the patient has not been tested for COVID-19. The patient reported that minutes after the injection, she had a metallic taste in her throat, strange sensation, and then very rapid heart rate. It subsided in about two minutes. The patient did not receive any treatment for the events. The patient recovered from the events. The events were reported as non-serious.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 1018348
Sex: F
Age:
State: WI

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sever joint pain hands, arms,shoulders; extreme fatigue; nausea; muscle fatigue; chills for 6 hours; swollen lymph nodes left side; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), via an unspecified route of administration at the left arm on 22Jan2021 10:00 at single dose for COVID-19 immunization. Medical history included heart disorder (heart disease), hypertension, and obesity. The patient was not pregnant at the time of vaccination. The patient was diagnosed with COVID-19 prior to vaccination. The patient received other medications within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced sever joint pain hands, arms, shoulders, extreme fatigue, nausea, muscle fatigue, chills (for 6 hours as reported), swollen lymph nodes left side all on 23Jan2021 02:00 with outcome of recovering. The patient did not received any treatment for the events.

Other Meds:

Current Illness:

ID: 1018349
Sex: M
Age:
State:

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: lower back muscle twitching; At 20Jan2021 04:30 woke up with his left lower back muscle twitching; back and neck stiffness; soreness in left arm (injection arm); This is a spontaneous report from a contactable physician (patient). A 65-year-old male patient received first dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine, lot number EL8982), via an unspecified route of administration at Arm Left on 19Jan2021 08:45 at the 65 years old at single dose for COVID-19 immunization. The medical history and concomitant medications were not reported. At 19Jan2021 13:45 the patient experienced soreness in left arm (injection arm) and took 800 mg Motrin. At 19Jan2021 20:00 developed back and neck stiffness. Took another dose of Motrin. At 20Jan2021 04:30 woke up with his left lower back muscle twitching. He felt back asleep and woke up at 20Jan2021 8:00 will all symptoms resolved. The outcome of the events soreness in left arm, back and neck stiffness, lower back muscle twitching was recovered on 20Jan2021 08:00, the event woke up was recovered on 20Jan2021.

Other Meds:

Current Illness:

ID: 1018350
Sex: F
Age:
State: TN

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Arm was extremely sore; Felt very fatigued and achy; Felt very fatigued and achy; Stomach is still upset; Haven't felt like doing anything; Nausea; Abdominal pain; Threw up twice; This is a spontaneous report from a contactable healthcare professional (patient). A 43-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported), intramuscularly on the right arm on 20Jan2021 (16:00) at a single dose for COVID-19 immunization at the hospital. The patient's medical history was not reported. Concomitant medications included fluoxetine hydrochloride (PROZAC), spironolactone, fluticasone propionate (FLONASE), cetirizine hydrochloride (ZYRTEC) and desogestrel, ethinylestradiol (MIRCETTE). The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 30Dec2020 (when the patient was 43 years old) on the left arm for COVID-19 immunization. The patient was not pregnant at the time of vaccination. On the day of the vaccination, the patient was fine. The following day, 21Jan2021 (16:30), the patient's arm was extremely sore; she had felt very fatigued and achy; stomach was upset; and had not felt like doing anything. On 21Jan2021, at night, the patient had nausea, abdominal pain, and had threw up twice. The patient did not receive any treatment for the events. The outcome of the events, 'arm was extremely sore', 'felt very fatigued and achy', 'stomach was upset', 'had not felt like doing anything', 'nausea', 'abdominal pain' and 'threw up', was recovering. The patient was not diagnosed with COVID-19 prior to the vaccination, and had not been tested since the vaccination. Information on the lot/batch number has been requested.

Other Meds: PROZAC; SPIRONOLACTONE; FLONASE [FLUTICASONE PROPIONATE]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; MIRCETTE

Current Illness:

ID: 1018351
Sex: F
Age:
State:

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: My arm I can barely move it, it's really painful; My arm I can barely move it, it's really painful; The initial case was missing the following minimum criteria: No adverse effect. Upon receipt of follow-up information on 24Jan2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration first dose on 23Jan2021 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that patient got the first dose on 23Jan2021 and patient arm can barely move it and just wanted to know if she can take Ibuprofen, I mean it was really painful. It was also described as "My arm I can barely move it, it's really painful". The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018352
Sex: F
Age:
State: AZ

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swelling of lymph nodes in her armpit on the same side; This is a spontaneous report from a contactable consumer (patient). This 40-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 20Jan2021 (at the age of 40-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was not provided. Concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 (lot number EL1284) on 30Dec2020 for COVID-19 immunization.The patient reported swelling of lymph nodes in her armpit on the same side that she received BNT162B2 which she noticed yesterday around noon (as of 22Jan2020). She wanted to report, further asking if it was common and how long it would last. She noted that this event was not seen with the first dose and was unsure if this was normal or not. The patient took ibuprofen for treatment. The clinical outcome of swelling of lymph nodes in her armpit on the same side was reported as not recovered. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1018353
Sex: F
Age:
State: CA

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: her left arm is still sore at the injection site; an area about "a quarter of an inch" was burning on the left side of her arm; entire arm felt like it was going to fall off "it was so sore"; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 05Jan2021 as a single dose in the left arm for COVID-19 immunization. Medical history included a tooth had been bothering her from an unknown date and was ongoing. Concomitant medications were not reported. In Jan2021 (since her first vaccination), the patient experienced her left arm was still sore at the injection site, an area about "a quarter of an inch" was burning on the left side of her arm and on Saturday her entire arm felt like it was going to fall off "it was so sore". The clinical outcome of the events vaccination site pain, skin burning sensation and pain in extremity was not recovered. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness: Tooth discomfort

ID: 1018354
Sex: F
Age:
State:

Vax Date: 01/20/2021
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: bad nausea; diarrhea; chills; feels very cold; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age (age: 79, unit: unspecified) received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine), via an unspecified route of administration on 20Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced bad nausea, diarrhea, chills and felt very cold on an unspecified date. Outcome of the events was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018355
Sex: F
Age:
State: AZ

Vax Date: 01/04/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen lymph node on R side of neck; This is a spontaneous report from a contactable healthcare professional (patient). A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported), intramuscularly on the left arm on 04Jan2021 (10:00) at a single dose for COVID-19 immunization at the hospital. Medical history included migraines and penicillin allergy. There were no concomitant medications. The patient previously took chlorhexidine gluconate (HIBICLENS), and had drug allergy. The patient was not pregnant at the time of vaccination. On 23Jan2021 (16:00), the patient had swollen lymph node on the right (R) side of the neck. The patient did not receive any treatment for the reported event. The outcome of the event, swollen lymph node on the right side of the neck, was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination, and was not tested post-vaccination. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018356
Sex: M
Age:
State: FL

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Name: COVID-19 test; Test Result: Negative

Allergies:

Symptoms: marginal pain 3 inches below the injection site/arm sore; This is a spontaneous report from a contactable Other Health Professional (patient). A 65-year-old male patient received 1st dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: FL9263), intramuscularly on 22Jan2021 at single dose for COVID-19 immunisation. Medical history included type 2 diabetes. Concomitant medication included metformin for type 2 diabetes and rosuvastatin for unknown indication. Patient reported marginal pain 3 inches below the injection site as his only side effect. His arm was sore, a little late last night. Maybe later last night (22Jan2021), so maybe 8 hours after the injection. Patient meant the injection was painless. Patient stated, "A little bit. It's not that bad, it's better, it is improved." Treatment included "Ice pack". His second dose was scheduled for 19Feb2021, 4 weeks after the first dose. Patient had COVID-19 test on unknown date and was negative. Outcome of the event was resolving.

Other Meds: METFORMIN; ROSUVASTATIN

Current Illness:

ID: 1018357
Sex: F
Age:
State: MI

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: temp; Result Unstructured Data: Test Result:low grade

Allergies:

Symptoms: the following morning low grade temp; chills; I also had areas of pain in my spine; I also had areas of pain in my spine, lower back; the pain( a dull ache) radiated over to both sides of my kidneys off and on; I was sweaty and fatigued; I was sweaty and fatigued; joint pains; My right Arm was sore at injection site/real bad arm soreness; This is a spontaneous report from a contactable healthcare professional (patient). A 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration in right arm on 21Jan2021 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 21Jan2021, patient received her 1st vaccine dose and her right arm was sore at injection site. Then the following morning (22Jan2021) she had low grade temp and chills and real bad arm soreness. She also had areas of pain in her spine, lower back and the pain (a dull ache) radiated over to both sides of her kidneys off and on, on 22Jan2021. She took Advil and felt better. That night (22Jan2021) she woke up during the night with the chills really bad and had a low grade temp and she was sweaty and fatigued. Felt ok most of the day yesterday (22Jan2021), some joint pains. She went to sleep last night and woke up because of chills, low grade temp and aching in my spine again. Woke up later last night and she was sweaty. Today, she was doing fine and took some Advil this morning. Patient was nervous about taking the second dose because of the symptoms she was having because she experienced these side effects. She wanted to know if it will be worse with the 2nd shot. Outcome of the events was recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018358
Sex: F
Age:
State: TN

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection site pain; headache; muscle pain; Joint pain; chills; fever (100.9-103.6); feeling very unwell.; first dose was given on 04Jan2021 and the second was on 21Jan2021; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: GL3302, expiration date was not reported), via an unspecified route of administration on 21Jan2021 09:00 at a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included vilazodone hydrochloride (VIIBRYD), quetiapine, and mirtazapine (MIRTAZEPINE TEVA). She was not pregnant. She had no known allergies. Historical vaccine included first dose of PFIZER BIONTECH COVID 19 VACCINE (lot number: EJ1685) on 04Jan2021 in the left arm when the patient was 31-years old for COVID-19 immunization. The patient had no any other vaccine in four weeks prior covid vaccine. The patient had no covid prior vaccination. She was not tested for covid post vaccination. The patient experienced injection site pain, headache, muscle pain, joint pain, chills, fever (100.9- 103.6), and feeling very unwell, all on 21Jan2021 10:00 PM with outcome of recovered on an unknown date in 2021. It was reported that the first dose was given on 04Jan2021 and the second was on 21Jan2021. No treatment received for the events.

Other Meds: VIIBRYD; QUETIAPINE; MIRTAZEPINE TEVA

Current Illness:

ID: 1018359
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain; knee swelling; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced pain, and knee swelling after getting the first dose of the vaccine on an unspecified date. Outcome of the events was unknown. Information about Lot/ Batch has been requested.

Other Meds:

Current Illness:

ID: 1018360
Sex: M
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: skin disease; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable consumer (wife) reported that the husband (male) patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 21Jan2021 at SINGLE DOSE for COVID-19 immunization. Medical history and concomitant medications were not reported. It was reported that yesterday (in Jan2021), her husband was prescribed with cefalexin (KEFLEX) for a skin disease not in relation to the vaccine for 4 times a day for 5 days straight. The wife asked it would be ok to take cefalexin on top of the COVID 19 vaccine. Outcome of the event was unknown. No follow-up attempts are possible, information about lot/batch cannot be obtained.; Sender's Comments: The event skin disease is likely intercurrent and is unrelated to suspect drug BNT162B2.

Other Meds:

Current Illness:

ID: 1018361
Sex: F
Age:
State: VA

Vax Date: 01/07/2021
Onset Date: 01/10/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: fever; Result Unstructured Data: Test Result:101; Comments: approximately 4:30pm; Test Date: 20210115; Test Name: PCR; Test Result: Negative ; Test Date: 20210115; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Fever of 101 at around 4:30 Temp did not go under 100.4 until 18Jan2021; severe fatigue; joint pain; This is a spontaneous report from a contactable health care professional nurse, the patient. A 46-years-old non-pregnant female patient (nurse) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EK4176), intramuscular in the left arm on 07JAN2021 at 08:15 as a single dose, for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was a Hospital Past drug allergy includes drug hypersensitivity to Avelox, Naprosyn, and ibuprofen. Relevant medical history includes molds allergy, dust/dander allergy and pollens allergy. Concomitant medication included meloxicam (MOBIC), ethinylestradiol, norgestimate (TRINESSA), phentermine (PHENTERMINE). No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. On 10JAN2021 at 14:00, the patient experienced severe fatigue, joint pain continued until 13Jan2021. On 12JAN2021 at 16:30, the patient experienced Fever of 101 at around 4:30, Temp did not go under 100.4 until 18Jan2021. Post vaccination, the patient had been tested for COVID-19. The patient underwent lab tests which included body temperature: 101 on 12Jan2021 at approximately 4:30pm; (PCR) polymerase chain reaction results negative on 15Jan2021, and Nasal Swab sars-cov-2 test results negative on 15Jan2021. The adverse events resulted in a Physician Office Visit. Treatment included Tylenol for aches. The clinical outcome of fever and fatigue was recovered on an unspecified date and Joint pain was recovered on 13Jan2021. .

Other Meds: MOBIC; TRINESSA; PHENTERMINE

Current Illness:

ID: 1018362
Sex: F
Age:
State: IN

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: face looks a little bit swollen; super tired; light dry cough /Light coughing; feeling like weakness; bone pain; muscle ache; She had some prior ache before but today it was stronger; This is a spontaneous report from a contactable consumer (daughter). A 70-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number EJ8982 and Expiration Date unknown) via an unspecified route of administration on 22Jan2021 at single dose for COVID-19 immunisation. The patient's medical history included rheumatoid arthritis, blood pressure high, had Corona virus before in Nov2020, and ongoing ache. The concomitant medication was reported as Lisinopril at 10 mg, one tablet a day for Blood pressure high and Vitamins. Patient woke up this morning (23Jan2021) super tired, light dry cough and face looks a little bit swollen. No just tired, she was feeling like weakness, a lot bone pain or muscle ache like a lot. The patient had some prior ache before but today it was stronger. She still feels some pain. Treatment for bone pain or muscle ache, pain was Ibuprofen. The reporter wanted to know if these symptoms are common reactions to the vaccine; if the COVID-19 vaccine can give a COVID-19 infection; if patient should receive the second dose of the COVID-19 vaccine since she was having these side effects. The outcome of events, bone pain or muscle ache, pain was not recovered. The outcome of other events were unknown. No follow-up attempts are possible. No further information is expected.

Other Meds: LISINOPRIL

Current Illness: Ache

ID: 1018363
Sex: F
Age:
State: CA

Vax Date: 01/13/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Very heavy sweats; Entire body tingling started; Body felt hot all over; Body just felt weird and off; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration in left arm, on 13Jan2021 at 18:00, at a single dose, for COVID-19 immunization. The patient's medical history included allergies to penicillin. The patient's concomitant medications included ergocalciferol (VITAMIN D) and ethinylestradiol/ norgestimate (ORTHO TRI-CYCLEN). The patient was not diagnosed with COVID-19 prior to vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On 15Jan2021 (day 2; also reported as 08Jan2021), entire body tingling started. On days 3 and 4 (16Jan2021 and 17Jan2021), the patient had very heavy sweats. No fever, just body felt hot all over, and body just felt weird and off in Jan2021. The side effects went away on day 9 (22Jan2021). No treatment was given for the adverse events. The patient had not been tested for COVID-19 post-vaccination. The patient recovered from the events on 22Jan2021. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds: VITAMIN D [ERGOCALCIFEROL]; ORTHO TRI-CYCLEN

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm